These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 30978511)

  • 1. Vascular white matter lesions negatively correlate with brain metastases in malignant melanoma-Results from a retrospective comparative analysis.
    Berk BA; Hering K; Kortmann RD; Hoffmann KT; Ziemer M; Seidel C
    Clin Neurol Neurosurg; 2019 May; 180():117-121. PubMed ID: 30978511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. White matter lesions reduce number of brain metastases in different cancers: a high-resolution MRI study.
    Berk BA; Nagel S; Hering K; Paschke S; Hoffmann KT; Kortmann RD; Gaudino C; Seidel C
    J Neurooncol; 2016 Oct; 130(1):203-209. PubMed ID: 27535745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between white matter lesions and cerebral Aβ burden.
    Yi HA; Won KS; Chang HW; Kim HW
    PLoS One; 2018; 13(9):e0204313. PubMed ID: 30248123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early imaging radioresponsiveness of melanoma brain metastases as a predictor of patient prognosis.
    Zubatkina I; Ivanov P
    J Neurosurg; 2018 Aug; 129(2):354-365. PubMed ID: 28841116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting brain metastases for non-small cell lung cancer based on magnetic resonance imaging.
    Yin G; Li C; Chen H; Luo Y; Orlandini LC; Wang P; Lang J
    Clin Exp Metastasis; 2017 Feb; 34(2):115-124. PubMed ID: 28101700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between 24-Hour Ambulatory Blood Pressure Variability and White Matter Lesions in Patients with Cerebral Small Vascular Disease: A Cross-Sectional Study.
    Liu P; Yin C; Liu M; Chang L; Wu T; Li Z; Luo R; Du X; Zhao W
    Comput Math Methods Med; 2022; 2022():6364769. PubMed ID: 35979055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. White matter lesions in treated late onset Pompe disease are not different to matched controls.
    Schneider I; Hensel O; Zierz S
    Mol Genet Metab; 2019 Jun; 127(2):128-131. PubMed ID: 31153821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative Rapid Assessment of Leukoaraiosis in CT : Comparison to Gold Standard MRI.
    Hanning U; Sporns PB; Schmidt R; Niederstadt T; Minnerup J; Bier G; Knecht S; Kemmling A
    Clin Neuroradiol; 2019 Mar; 29(1):109-115. PubMed ID: 29058014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility-weighted imaging in malignant melanoma brain metastasis.
    Schwarz D; Niederle T; Münch P; Hielscher T; Hassel JC; Schlemmer HP; Platten M; Winkler F; Wick W; Heiland S; Delorme S; Bendszus M; Bäumer P; Breckwoldt MO
    J Magn Reson Imaging; 2019 Oct; 50(4):1251-1259. PubMed ID: 30793419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of frequency of deep white matter metastasis on cerebral MRI.
    Seidel C; Hambsch P; Hering K; Bresch A; Rohde S; Kortmann RD; Gaudino C
    J Neurooncol; 2015 May; 123(1):135-9. PubMed ID: 25894593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship of leukoaraiosis and the clinical severity of vascular Parkinsonism.
    Chen YF; Tseng YL; Lan MY; Lai SL; Su CS; Liu JS; Chang YY
    J Neurol Sci; 2014 Nov; 346(1-2):255-9. PubMed ID: 25240444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classifying brain metastases by their primary site of origin using a radiomics approach based on texture analysis: a feasibility study.
    Ortiz-Ramón R; Larroza A; Ruiz-España S; Arana E; Moratal D
    Eur Radiol; 2018 Nov; 28(11):4514-4523. PubMed ID: 29761357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative impact of leukoaraiosis on the incidence of brain metastases in patients with lung cancer.
    Hayashi N; Mitsuya K; Nakasu Y; Naito T; Ohka F; Takahashi T
    J Neurooncol; 2017 Nov; 135(2):299-306. PubMed ID: 28752500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for brain metastases in patients with stage III non-small-cell lung cancer, magnetic resonance imaging or computed tomography? A prospective study.
    Schoenmaekers J; Hofman P; Bootsma G; Westenend M; de Booij M; Schreurs W; Houben R; De Ruysscher D; Dingemans AM; Hendriks LEL
    Eur J Cancer; 2019 Jul; 115():88-96. PubMed ID: 31129385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular risk and white matter lesions after endocrine control of Cushing's syndrome.
    Santos A; Resmini E; Gómez-Ansón B; Crespo I; Granell E; Valassi E; Pires P; Vives-Gilabert Y; Martínez-Momblán MA; de Juan M; Mataró M; Webb SM
    Eur J Endocrinol; 2015 Dec; 173(6):765-75. PubMed ID: 26497546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-related Perfusion Changes in White Matter Adjacent to Brain Tumors: Pharmacodynamic Analysis of Dynamic 3T Magnetic Resonance Imaging.
    Tupý R; Mírka H; Mraček J; Přibáň V; Hes O; Vokurka S; Ferda J
    Anticancer Res; 2018 Jul; 38(7):4149-4152. PubMed ID: 29970543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of White Matter Hyperintensities With Short-Term Outcomes in Patients With Minor Cerebrovascular Events.
    Zerna C; Yu AYX; Modi J; Patel SK; Coulter JI; Smith EE; Coutts SB
    Stroke; 2018 Apr; 49(4):919-923. PubMed ID: 29540612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The presentation of brain metastases in melanoma, non-small cell lung cancer, and breast cancer and potential implications for screening brain MRIs.
    Mills MN; Potluri TK; Kawahara Y; Fahey M; Figura NB; Soyano AE; Washington IR; Diaz R; Oliver DE; Yu HM; Etame AB; Vogelbaum MA; Czerniecki BJ; Arrington JA; Sahebjam S; Forsyth PA; Soliman HH; Han HS; Ahmed KA
    Breast Cancer Res Treat; 2022 Jan; 191(1):209-217. PubMed ID: 34669082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood pressure and white matter lesions in patients with vascular disease: the SMART-MR study.
    Vlek AL; Visseren FL; Kappelle LJ; Witkamp TD; Vincken KL; Mali WP; van der Graaf Y;
    Curr Neurovasc Res; 2009 Aug; 6(3):155-62. PubMed ID: 19534721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
    Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.